水汽
发表于 2025-3-23 10:11:43
http://reply.papertrans.cn/47/4665/466473/466473_11.png
ostensible
发表于 2025-3-23 17:40:59
http://reply.papertrans.cn/47/4665/466473/466473_12.png
emission
发表于 2025-3-23 20:11:54
The Pathophysiological Basis of Parkinson’s Diseaseof the central nervous system (CNS), and is basically characterized by dysfunction of the dopaminergic nigro-striatal system. It may, or in rare cases it may not, be associated with distinct anatomical damage to melanin-containing neurons of the substantia nigra (SN), changes in the neuronal cytoske
特别容易碎
发表于 2025-3-23 23:08:20
Parkinson’s Disease and Its Existing Therapyntal disturbances and disorders of the autonomic nervous system. The degree and combination of the symptoms vary from case to case and during the course of the disease. With consideration of the motor signs of the disease, an akinetic-rigid and a tremor-dominant progress type is differentiated. Equa
SOW
发表于 2025-3-24 05:58:56
Medicinal Chemistry of Present and Future MAO-B Inhibitorsients still suffered from tuberculosis. Then, several groups of chemists synthesized molecules with different chemical structures in attempts to create an efficient treatment for this illness. One of these compounds, isonicotinyl hydrazide (isoniazid) was originally synthesized as a necessary interm
craven
发表于 2025-3-24 08:55:23
-Deprenyl: A Unique MAO-B Inhibitors to catalyze the oxidative deamination of biogenic amines to the corresponding aldehyde . It is generally accepted that it exists in two functional isoenzyme forms, MAO-A and MAO-B, each of which shows preferential affinity for substrates and specificity towards inhibitors . Available evid
最初
发表于 2025-3-24 10:40:21
http://reply.papertrans.cn/47/4665/466473/466473_17.png
transdermal
发表于 2025-3-24 16:03:56
http://reply.papertrans.cn/47/4665/466473/466473_18.png
Anterior
发表于 2025-3-24 21:48:04
http://reply.papertrans.cn/47/4665/466473/466473_19.png
Mets552
发表于 2025-3-25 01:19:18
Pharmacokinetics and Clinical Pharmacology of Selegilineetabolized via MAO-B . By inhibiting this enzyme the dopamine concentration in the brain is increased . Selegiline has also been shown to inhibit the uptake of dopamine and noradrenaline . Due to these properties, selegiline is widely used in the treatment of Parkinson’s disease (PD) as eit